Charles River Laboratories International Inc (CRL)

104.11
0.13 0.13
NYSE : Health Care
Prev Close 103.98
Open 103.65
Day Low/High 103.42 / 104.90
52 Wk Low/High 67.20 / 104.09
Volume 168.85K
Avg Volume 312.20K
Exchange NYSE
Shares Outstanding 47.59M
Market Cap 4.82B
EPS 3.30
P/E Ratio 26.70
Div & Yield N.A. (N.A)

Latest News

Charles River Laboratories Acquires Brains On-Line

Charles River Laboratories Acquires Brains On-Line

Charles River Laboratories International, Inc. (NYSE: CRL) today announced that it has acquired Brains On-Line, a leading contract research organization (CRO) providing critical data that advances novel therapeutics for the...

Charles River Laboratories Schedules Second-Quarter 2017 Earnings Release And Conference Call

Charles River Laboratories Schedules Second-Quarter 2017 Earnings Release And Conference Call

Charles River Laboratories International, Inc. (NYSE: CRL) will release second-quarter 2017 financial results on Wednesday, August 9 th, before the market opens.

Charles River Laboratories Adds Martin Mackay, Ph.D. To Board Of Directors

Charles River Laboratories Adds Martin Mackay, Ph.D. To Board Of Directors

Charles River Laboratories International, Inc. (NYSE:CRL) today announced the appointment of Dr.

Charles River Laboratories To Present At Jefferies Global Healthcare Conference

Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will present at the Jefferies 2017 Global Healthcare Conference in New York on Wednesday, June 7 th, at 10:00 a.

Advanced Micro Devices, Micron Technology, Charles River Labs: 'Mad Money' Lightning Round

Advanced Micro Devices, Micron Technology, Charles River Labs: 'Mad Money' Lightning Round

Jim Cramer is bullish on Advanced Micro Devices, Micron Technology, and Charles River Labs.

Profits Trump Economic Weakness: Cramer's 'Mad Money' Recap (Friday 6/2/17)

Profits Trump Economic Weakness: Cramer's 'Mad Money' Recap (Friday 6/2/17)

Jim Cramer has the game plan for next week, including earnings from Thor Industries and HD Supply.

Charles River Laboratories Announces Updates To Oncology Business

Charles River Laboratories International, Inc. (NYSE: CRL) recently announced updates to its expanding oncology discovery business, including significant additions to its online Tumor Model Compendium.

Short Interest Falls 27% For CRL

The most recent short interest data has been released for the 04/28/2017 settlement date, which shows a 605,992 share decrease in total short interest for Charles River Laboratories International Inc. , to 1,645,180, a decrease of 26.92% since 04/13/2017.

Charles River Laboratories Announces First-Quarter 2017 Results From Continuing Operations

Charles River Laboratories International, Inc. (NYSE: CRL) today reported its results for the first quarter of 2017.

Charles River Laboratories Schedules First-Quarter 2017 Earnings Release And Conference Call

Charles River Laboratories International, Inc. (NYSE: CRL) will release first-quarter 2017 financial results on Wednesday, May 10 th before the market opens.

Parexel Is Discovering the Drugs of the Future

Parexel Is Discovering the Drugs of the Future

The midcap drug maker is finding growth as an outsourcing destination.

Http://www.nimbustx.com/

Nimbus Therapeutics and Charles River Laboratories International, Inc.

Charles River Laboratories Announces Launch Of Triple-Immunodeficient Mouse Model For Oncology Research

Charles River Laboratories International, Inc. (NYSE: CRL), a leading early-stage contract research organization (CRO), announced the North American launch of its triple-immunodeficient mouse model, known as the NCG...

Charles River Laboratories And Chiesi Farmaceutici SpA Announce Extension Of Integrated Respiratory Drug Discovery Program

Charles River Laboratories International, Inc. (NYSE: CRL), a leading early-stage contract research organization (CRO), today announced that it has extended its longstanding, strategic, integrated drug discovery partnership...

Charles River Laboratories To Present At Raymond James And Barclays Conferences

Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will present at the Raymond James 38 th Annual Institutional Investors Conference in Orlando, Florida on Tuesday, March 7 th, at 1:05 p.

Charles River Laboratories Announces Fourth-Quarter And Full-Year 2016 Results From Continuing Operations And Provides 2017 Guidance

Charles River Laboratories International, Inc. (NYSE: CRL) today reported its results for the fourth-quarter and full-year 2016 and provided guidance for 2017.

Charles River Laboratories International Stock Sees Short Interest Make 64.5% Move

The most recent short interest data has been released for the 01/31/2017 settlement date, which shows a 849,583 share increase in total short interest for Charles River Laboratories International Inc. , to 2,167,328, an increase of 64.47% since 01/13/2017.

Charles River Laboratories Changes Time Of Fourth-Quarter 2016 Earnings And 2017 Guidance Conference Call

Charles River Laboratories International, Inc. (NYSE:CRL) announced today that it changed the time of its conference call to discuss fourth-quarter and full-year 2016 financial results and 2017 guidance to 8:00 a.

Charles River Laboratories Announces Progress Update For Collaboration With Moderna Therapeutics

Charles River Laboratories International, Inc. (NYSE:CRL), a leading early-stage contract research organization (CRO), today announced a progress update related to its support of Moderna Therapeutics'...

Charles River Laboratories Schedules Fourth-Quarter 2016 Earnings And 2017 Guidance Release And Conference Call

Charles River Laboratories Schedules Fourth-Quarter 2016 Earnings And 2017 Guidance Release And Conference Call

Charles River Laboratories International, Inc. (NYSE: CRL) will release fourth-quarter and full-year 2016 financial results and provide 2017 guidance on Tuesday, February 14 th, before the market opens.

Charles River Laboratories To Present At J.P. Morgan Healthcare Conference

Charles River Laboratories To Present At J.P. Morgan Healthcare Conference

Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will present at the 35 th Annual J.

Analysts' Actions -- GE, Nordstrom, Coca-Cola, Eli Lilly and More

Analysts' Actions -- GE, Nordstrom, Coca-Cola, Eli Lilly and More

Here are Friday's top research calls, including upgrades for Eli Lilly, Regeneron and GE, and downgrades for Nordstrom, Coca-Cola, Apache and Duke Energy.

Charles River Laboratories Demonstrates Expertise In CRISPR/Cas9 Genome Engineering Technology

Charles River Laboratories Demonstrates Expertise In CRISPR/Cas9 Genome Engineering Technology

Charles River Laboratories International, Inc. (NYSE: CRL) today launched a full, end-to-end service offering of CRISPR/Cas9 genome engineering technology.

Charles River Laboratories Presents Robust Program At Neuroscience 2016

Charles River Laboratories Presents Robust Program At Neuroscience 2016

Charles River Laboratories International, Inc. (NYSE: CRL) today announced that its team of leading Central Nervous System (CNS) and neurological disease experts is presenting 25 scientific posters and one podium...

Trader's Daily Notebook: For a Decline, It Sure Was Smooth

But we could see more volatility in the market.

Charles River Laboratories Announces Third-Quarter 2016 Results From Continuing Operations

Charles River Laboratories Announces Third-Quarter 2016 Results From Continuing Operations

Charles River Laboratories International, Inc. (NYSE: CRL) today reported its results for the third quarter of 2016.

Charles River Announces Extension Of Integrated Discovery Program With Genentech

Charles River Announces Extension Of Integrated Discovery Program With Genentech

Charles River Laboratories International, Inc. (NYSE: CRL) today announced that it has extended its longstanding integrated drug discovery alliance with Genentech, a member of the Roche Group.

Charles River Laboratories Schedules Third-Quarter 2016 Earnings Release And Conference Call

Charles River Laboratories Schedules Third-Quarter 2016 Earnings Release And Conference Call

Charles River Laboratories International, Inc. (NYSE: CRL) will release third-quarter 2016 financial results on Wednesday, November 2 nd before the market opens.